In a groundbreaking study, scientists from the National University of Singapore (NUS) have introduced an innovative technique that leverages DNA ‘barcodes’ to identify which gold nanoparticles can most effectively target and treat cancer at its core. This approach, published in the journal Advanced Materials, promises to enhance cancer treatments significantly by focusing on mitochondria, the powerhouse organelles within cancerous cells.
The method uses DNA barcoding to tag various designs of gold nanoparticles, enabling researchers to track their effectiveness dynamically within living tumor models. This innovation facilitates a rapid evaluation of each nanoparticle design’s ability to reach and influence mitochondria. Under the leadership of Assistant Professor Andy Tay, the study demonstrated specific nanoparticle formulations capable of inducing significant tumor regression, highlighting an unprecedented precision in the delivery of therapeutics.
Remarkably, the study identified two types of nanoparticle designs as exceptionally effective. Among them, folic acid-modified cubic nanoparticles showed outstanding results, achieving up to 99% tumor regression in preclinical models. This was achieved in conjunction with mitochondrial-targeted RNA therapy and mild photothermal treatment. This combination does not just target cancer cells; it also modifies immune cells’ responses, potentially altering the tumor’s immune environment and thereby enhancing therapeutic outcomes significantly.
The research underscores the crucial role of nanoparticle properties—such as shape, size, and surface chemistry—in successfully targeting tumors and facilitating subcellular delivery. This marks a substantial advancement towards precision nanomedicine. Furthermore, the high-throughput screening platform developed by the NUS team minimizes reliance on animal models, accelerating the design processes for targeted therapies.
Ultimately, the study emphasizes the potential of DNA-barcoded nanoparticles in the precise delivery of cancer therapies. This represents a significant leap towards personalized medicine. Future research could involve expanding the nanoparticle library and incorporating artificial intelligence to optimize their design and effectiveness further. Such advancements could lead to tailored treatments for various diseases beyond cancer, ushering in a new era in medical science.